Drugs / Lcr35®
last change Apr 2012 re-read 3 minutes ago

Lcr35®

Developed for
bacterial vaginosis
Investigated by
Laboratoires Lyocentre

Trials 1

201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT01160796 Jun 2010 → May 2011 bacterial vaginosis Laboratoires Lyocentre Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Lcr35 ClinicalTrials.gov intervention name — accepted as the source's own label NCT01160796 ↗
Route Other “Total Freeze-dried Culture of Lactobacillus Casei Var. Rhamnosus (Lcr35®) Administered Intravaginally” NCT01160796 ↗